Measurement of beta_s at CDF

The latest results for the measurement of the CP violating phase beta_s in B0s -> J/psi phi decays, from 5.2 fb-1 integrated luminosity of CDF data are presented. For the first time, this measurement includes the contribution of B0s -> J/psi K+K- or B0s -> J/psi f0 events to the signal sample, where the f0 and non-resonant K+K- are S-wave states. Additional improvements to the analysis include more than doubling the signal sample, improved selection and particle ID, and fully calibrated flavour tagging for the full dataset. Additionally, the world's most precise single measurements of the B0s lifetime, tau_s, and width difference, DeltaGamma_s are given.Comment: Proceedings of FPCP 2010, 7 pages, 4 figure

Dark matter line searches towards dwarf galaxies with H.E.S.S

High energy $gamma$-rays are powerful probes in the search for annihilations of dark matter (DM) par- ticles in dense environments. In several DM particle models their annihilation produces characteristic features such as lines, bumps or cut-offs in their energy spectrum. The High Energy Stereoscopic System (H.E.S.S.) of imaging atmospheric Cherenkov telescopes is perfectly suited to search for such features from multi-TeV mass DM particles. The Dwarf Spheroidal Galaxies (dSphs) of the Local Group are the most common satellites of the Milky Way and assumed to be gravitationally bound dominantly by DM, with up to O(10 3 ) times more mass in DM than in visible matter. Over the past decade, several observational campaigns on dwarf satellite galaxies were launched by H.E.S.S. amounting to more than 140 hours of exposure in total. The observations are reviewed here. In the absence of clear signals, the expected spectral and spatial morphologies of signal and background are used to derive constraints on the DM particle annihilation cross- section for particle models producing line-like signals. The combination of the data of all the dwarf galaxies allows a significant improvement in the HESS sensitivity

Attributing minds to vampires in Richard Matheson’s I Am Legend

For Palmer (2004, 2010), and other proponents of a cognitive narratology, research into real-world minds in the cognitive sciences provides insights into readers’ experiences of fictional minds. In this article, I explore the application of such research to the minds constructed for the vampire characters in Richard Matheson’s (1954) science fiction/horror novel I Am Legend. I draw upon empirical research into ‘mind attribution’ in social psychology, and apply Cognitive Grammar (Langacker, 2008), and its notion of ‘construal’, as a framework for the application of such findings to narrative. In my analysis, I suggest that readers’ attribution of mental-states to the vampires in Matheson’s novel is strategically limited through a number of choices in their linguistic construal. Drawing on online reader responses to the novel, I argue that readers’ understanding of these other minds plays an important role in their empathetic experience and their ethical judgement of the novel’s main character and focaliser, Robert Neville. Finally, I suggest that the limited mind attribution for the vampires invited through their construal contributes to the presentation of a ‘mind style’ (Fowler, 1977) for this character

DSIF and RNA Polymerase II CTD Phosphorylation Coordinate the Recruitment of Rpd3S to Actively Transcribed Genes

Histone deacetylase Rpd3 is part of two distinct complexes: the large (Rpd3L) and small (Rpd3S) complexes. While Rpd3L targets specific promoters for gene repression, Rpd3S is recruited to ORFs to deacetylate histones in the wake of RNA polymerase II, to prevent cryptic initiation within genes. Methylation of histone H3 at lysine 36 by the Set2 methyltransferase is thought to mediate the recruitment of Rpd3S. Here, we confirm by ChIP–Chip that Rpd3S binds active ORFs. Surprisingly, however, Rpd3S is not recruited to all active genes, and its recruitment is Set2-independent. However, Rpd3S complexes recruited in the absence of H3K36 methylation appear to be inactive. Finally, we present evidence implicating the yeast DSIF complex (Spt4/5) and RNA polymerase II phosphorylation by Kin28 and Ctk1 in the recruitment of Rpd3S to active genes. Taken together, our data support a model where Set2-dependent histone H3 methylation is required for the activation of Rpd3S following its recruitment to the RNA polymerase II C-terminal domain

Effect of remote ischaemic conditioning on clinical outcomes in patients with acute myocardial infarction (CONDI-2/ERIC-PPCI): a single-blind randomised controlled trial.

BACKGROUND: Remote ischaemic conditioning with transient ischaemia and reperfusion applied to the arm has been shown to reduce myocardial infarct size in patients with ST-elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PPCI). We investigated whether remote ischaemic conditioning could reduce the incidence of cardiac death and hospitalisation for heart failure at 12 months. METHODS: We did an international investigator-initiated, prospective, single-blind, randomised controlled trial (CONDI-2/ERIC-PPCI) at 33 centres across the UK, Denmark, Spain, and Serbia. Patients (age >18 years) with suspected STEMI and who were eligible for PPCI were randomly allocated (1:1, stratified by centre with a permuted block method) to receive standard treatment (including a sham simulated remote ischaemic conditioning intervention at UK sites only) or remote ischaemic conditioning treatment (intermittent ischaemia and reperfusion applied to the arm through four cycles of 5-min inflation and 5-min deflation of an automated cuff device) before PPCI. Investigators responsible for data collection and outcome assessment were masked to treatment allocation. The primary combined endpoint was cardiac death or hospitalisation for heart failure at 12 months in the intention-to-treat population. This trial is registered with ClinicalTrials.gov (NCT02342522) and is completed. FINDINGS: Between Nov 6, 2013, and March 31, 2018, 5401 patients were randomly allocated to either the control group (n=2701) or the remote ischaemic conditioning group (n=2700). After exclusion of patients upon hospital arrival or loss to follow-up, 2569 patients in the control group and 2546 in the intervention group were included in the intention-to-treat analysis. At 12 months post-PPCI, the Kaplan-Meier-estimated frequencies of cardiac death or hospitalisation for heart failure (the primary endpoint) were 220 (8·6%) patients in the control group and 239 (9·4%) in the remote ischaemic conditioning group (hazard ratio 1·10 [95% CI 0·91-1·32], p=0·32 for intervention versus control). No important unexpected adverse events or side effects of remote ischaemic conditioning were observed. INTERPRETATION: Remote ischaemic conditioning does not improve clinical outcomes (cardiac death or hospitalisation for heart failure) at 12 months in patients with STEMI undergoing PPCI. FUNDING: British Heart Foundation, University College London Hospitals/University College London Biomedical Research Centre, Danish Innovation Foundation, Novo Nordisk Foundation, TrygFonden

Patients', nurses', and physicians' perceptions of quality nursing care

This item was digitized from a paper original and/or a microfilm copy. If you need higher-resolution images for any content in this item, please contact us at [email protected]